Company / CapEx per Share
Praxis Precision Medicines, Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.14
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#152 of 192
Health Care
What the data says
Praxis Precision Medicines, Inc.'s capex per share of $0.00 is lower than 79% of companies in the Health Care sector (FY2025). CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.00.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -72.9%.
Declined from $0.02 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -72.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 192This company $0.00 Sector average $3.54
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #152 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.02 | -89.5% |
| FY2022 | $0.14 | +484.2% |
| FY2021 | $0.02 | - |
| FY2020 | $0.00 | -100.0% |
| FY2019 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026